Clinical Trials & Pipeline
Clinical Trials & Pipeline
Millions of people worldwide are living with unmet health needs. At Bayer, our focus is to discover and develop medicines that provide the opportunity to live a healthier life. We are actively pursuing our vision to deliver best-in-class patient care, outcomes, and experience by advancing science.
Information on investigational compounds and clinical trials sponsored by Bayer is being shared to increase the transparency of Bayer's clinical research. Research sponsored by independent investigators is not included.
Ongoing Trials
Real World Prospective
Phase IV Study
PTPs 7 to <12 years
HEM-POWR Kids Phase IV Study
A study to describe the treatment outcomes of damoctocog alfa pegol prophylaxis in a real-world setting in previously treated patients aged 7 to <12 years with hemophilia A.
HEM-POWR Phase IV Study
A study to evaluate the effectiveness and long-term safety of damoctocog alfa pegol in previously treated patients with mild, moderate, and severe hemophilia A in a real-world clinical setting
Real World Prospective Phase IV Study
PTPs ≥12 years
Follow Us
